Benzinga | May 13, 2021 06:08AM EDT

BD Announces Industry-First CE Marked Assay for HPV Screening from At-Home Self-Collected Vaginal Samples

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced the industry's first self-collection claim for HPV screening has been CE marked to the IVD directive 98/79/EC.

The new claim allows laboratories and facilities to process self-collected samples via a BD diluent tube using the BD Onclarity(tm) HPV Assay on either the BD Viper(tm) LT or the BD COR(tm) System. The BD Viper(tm) LT is in use globally and the BD COR(tm) System, launched last year, is in use across Europe.